BARRELEYE
Quantitative US
AI solution for breast cancer
88%
Early diagnosis of breast cancer through AI technology reduces the fatality rate by more than 88%.
Early diagnosis of breast cancer through AI technology reduces the fatality rate by more than 88%.
160k
Biopson AI was trained through high-quality synthetic and clinical breast ultrasound data.
Biopson AI was trained through high-quality synthetic and clinical breast ultrasound data.
94%
The accuracy of diagnosing breast cancer through Biopson AIdetection solution reaches 94%.
The accuracy of diagnosing breast cancer through Biopson AIdetection solution reaches 94%.
Strongly correlated with MRI
0.91
0.91
88%
Early diagnosis of breast cancer through AI technology reduces the fatality rate by more than 88%.
Early diagnosis of breast cancer through AI technology reduces the fatality rate by more than 88%.
160k
Biopson AI was trained through high-quality synthetic and clinical breast ultrasound data.
Biopson AI was trained through high-quality synthetic and clinical breast ultrasound data.
94%
The accuracy of diagnosing breast cancer through Biopson AI detection solution reaches 94%.
The accuracy of diagnosing breast cancer through Biopson AI detection solution reaches 94%.
The most accurate AI solution for early diagnosis of breast cancer
Increases the possibility of early detection of breast cancer
.png)
.png)
.png)
.png)
.png)
Early diagnosis survival rate
98%
Survival rate upon failure
52%
Increases the possibility of
early detection of breast cancer.
early detection of breast cancer.
Early diagnosis survival rate
98%
Survival rate upon failure
52%
The most accurate AI solution for early diagnosis of breast cancer
Designed by Barreleye
Lesion Detection
Bipson detects abnormal lesion through AI technology in the inform of heatmaps and outlines
Tissue Analysis
The AI analysis quantitative bio-marker of tissue, and enhance accuracy of the diagnosis
AI Diagnosis
The AI provides an accurate diagnostic report that shows the disease characteristics of the tissue.
